OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-04-05-accounts

Page
Trust Information
Report ofthe Trustee 2-4
Report ofthe Auditor 5-7
Statement ofFinancial Activities
Balance Sheet
Statement ofCashflows 10
Accounting
Policies
11 - 12
Notes to the Financial Statements 13-17

Note 2022 2021f
Cash flow from operating activities (53,033) (71,970)
Net cash flow (used in) operating
activities
(53,033) (71,970)
Cash flow from investing activities
Payments
to acquire investments
(186,602) (74,737)
Receipts from sales of investments 408,446 100,000
Dividends,
interest and rents received
from investments 69,848 87,824
Movement
in cash held at investment
managers
(242,361) (25,594)
Foreign exchange losses (58) (2,271)
Net cash flow provided
by
investing activities 49,273 85,222
Change
in cash and cash
equivalents in the year (3,780) 13,252
Cash and cash equivalents at 8April 21,380 8,128
Cash and cash equivalents at 5April 17,520 21,380
Cash and cash equivalents consists of:
Cash at bank and
in hand
17,620 21,380
Cash and cash equivalents at 5April 17,620 21,380

.Ana lysis ofexpenditur e
on charitable
activities
Costs related Support
to charitable costs 2022 2021
activities Total Total
F 5 5
Grant awards 70,611 9,475 80,088 78,726
70,611 9,475 80,085 78,728

1.2. Support co sts
2022 2021
Total Total
5 5
Bank charges 68 61
Forex losses 197
Governance costs (see note 1.3) 9,407 9,057
Total support costs 9,475 9,315
1.3.Governance costs
2022 2021
5 F
Auditor's
remuneration
5,315 4,958
Legal and professional fees 4,092 4,099
9,407 9,057

Recipients ofgrants to institution institution s: s:
Grants payable
in the year
individually valued at more than F750are as follows:
2022 2021
5 8
Action on Hearing
Loss
1,000 1,000
AJEX 1,000 1,000
AMPA 2,500 2,500
Aldenham
School
1,000 1,000
Blond Mclndoe 1,000 1,000
Bournemouth
War Memorial
Homes 1,000 1,000
Brain and Spine Foundation 1,500 1,500
Cancer Research
UK
2,000 2,000
Chain of Hope 2,000 2,000
Childhood
First
2,000 2,000
Christie Charitable
Fund
1,000 1,000
CLIC Sargent 2,000 2,000
CST 5,000 5,000
Cystic Fibrosis 1,000 1,000
Diabetes UK 5,000 5,000
FFDJF 1,000 1,000
Eglise Orthodoxe
Russe
834
Fight for Sight 1,000 1,000
Great Ormand
Street Hospital
2,000 2,000
Holocaust
Educational
Trust
1,000 1,000
Huntington's
Disease Association
1,000 1,000
Jewish Association
for the
Physically Handicapped 1,000 1,000
Jewish Deaf Association 2,000 2,000
Jewish Lads and Girls Brigade 1,000 1,000
Leukaemia
Fund
1,000 1,000
Listening
Books
1,000 1,000
LPO PACA 911
Macular Society 1,000 1,000
Memorial
De la Shaoh
859
Motor Neurone
Disease Association
1,000 1,000
MTV Staying Alive Foundation 1,000 1,000
National
Deaf-Blind
& Rubella
Association 1,000
Nightingale
House
3,000 3,000
Norwood 2,500 2,500
Not Forgotten Association 1,000 1,000
Oxford 8 StGeorge's Jewish Youth Trust 1,000 1,000
Prostate Cancer UK 1,000 1,000
Queen
Elizabeth
Birmingham
2,000 2,000
Restoration
ofAppearance
and Function Trust 1,000 1,000
Royal Marsden
Cancer Charity
2,500 2,500
Royal National
institute of Blind People Charity
2,500 2,500
Rural Coffee Caravan 1,000 1,000
Skeleton Cancer Trust 1,000 1,000
SCAT 1,000 1,000
SENSE 1,000
SHINE 1,000 1,000
WIZO 1,000 1,000
Wellbeing
ofWomen
1,000 1,000
Carried forward 69,193 68,411
1.1. Analysis ofgrants (continued) 1.1. Analysis ofgrants (continued)
Brought forward 69,193 68,411
Individual
grants for 6750
or less 1,418 1,000
Total grant awards 70,611 69,411
Grants
in both years were
made from unrestricted funds.
2. Net expenditure
for the year
Net expenditure
is stated after charging:
2022f 2021
Auditor remuneration 5,315 4,958
3. Fixed asset investments
2022 2021
F 6
Market value at beginning ofyear 2,127,502 1,947,075
Additions
in the year
186,602 74,737
Disposals at opening
market value
in the year (418,398) (100,000)
(Losses)/Gains (276,722) 205,690
Market value at end ofyear 1,618,984 2,127,502
Cash held in investments
At beginning
ofyear
29,560 3,966
Movement
in the year
231,837 25,594
At end ofyear in the year 261,397 29,560
Investments
value at end
ofyear 1,880,381 2,157,062

4. Debtors
2022 2021
6 6
Accrued bond interest 22,432 33,301
5. Creditors: amounts falling due within one year
2022 2021
6 F
Accruals 4,977 4,577
Creditors 4,692
4,977 9,269
6. Funds reconciliation Funds reconciliation
Unrestricted funds movement
analysis
year ended 5April 2021
Balance at 6 Gains I Balance at 5
April 2021 Income Expenditure (losses) April 2022
6 6 6
Income 1,335,832 69,848 (80,086) (276,780) 1,048,814
Capital 866,642 666,642
2,202,474 69,848 (80,086) (276,708) 1,915,456
Unrestricted funds movement
analysis
year ended 5April 2021
Balance at 6 Gains I Balance at 5
April 2020f Income
6
Expenditure
F
(losses)
6
April 2021
6
Income 1,123,315 87,824 (78,726) 203,419 1,335,832
Capital 866,642 866,642
1,989,957 87,824 (78,726) 203,419 2,202,474
7. Reconciliation
ofnet expenditure
Reconciliation
ofnet expenditure
to net cash flow from operating activities
2022 2021
5
Net expenditure
for year before
gains and losses 10,238 9,098
Dividends,
interest and rents from
investments (69,848) (87,824)
Decrease/(Increase)
in debtors
10,869 1,924
(Decrease)/Increase
in creditors
(4,292) 4,832
Net cash flow from operating activities (53,033) (71,970)